These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 32376138)
1. Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2020;77:55-65: Assessing the Morbidity of Multimodal Approaches in Patients with Muscle-invasive Bladder Cancer. Vetterlein MW; Gild P; Fisch M; Rink M Eur Urol; 2020 Aug; 78(2):e77-e78. PubMed ID: 32376138 [No Abstract] [Full Text] [Related]
2. Reply to Liang Sun and Yi Feng's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2019;77:55-65: Importance of Surgical and Anesthesiological Standard Operating Procedures for Radical Cystectomy in a Bundled Care Setting. Vetterlein MW; Rink M Eur Urol; 2020 Jan; 77(1):e12-e13. PubMed ID: 31607396 [No Abstract] [Full Text] [Related]
3. Re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2020;77:55-65. Montorsi F; Bandini M; Necchi A Eur Urol; 2020 Aug; 78(2):e75-e76. PubMed ID: 32362494 [No Abstract] [Full Text] [Related]
4. Re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2019;77:55-65. Sun L; Feng Y Eur Urol; 2020 Jan; 77(1):e10-e11. PubMed ID: 31607395 [No Abstract] [Full Text] [Related]
5. Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Francesco Soria, Marco Moschini, David D'Andrea, et al. Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study. Eur Urol Focus 2020;6:1233-9. Soria F; D'Andrea D; Gontero P; Shariat SF Eur Urol Focus; 2022 Mar; 8(2):633-634. PubMed ID: 33875390 [No Abstract] [Full Text] [Related]
6. Reply to Francesco Montorsi, Marco Bandini, Alberto Briganti, et al. Re-establishing the Role of Robot-assisted Radical Cystectomy After the 2020 EAU Muscle-invasive and Metastatic Bladder Cancer Guideline Panel Recommendations. Eur Urol 2020;78:489-91: Can Open and Robotic Radical Cystectomy be Considered Equally Effective in 2020? Witjes JA; Ribal MJ; van der Heijden AG Eur Urol; 2020 Oct; 78(4):492-493. PubMed ID: 32693931 [No Abstract] [Full Text] [Related]
7. Reply to Marc A. Furrer and Patrick Y. Wuethrich's and Francesco Montorsi, Marco Moschini, Giorgio Gandaglia, and Alberto Briganti's Letters to the Editor re: Jakob Klemm, Michael Rink, Markus Von Deimling, et al. Time-to-complication Patterns After Radical Cystectomy: A Secondary Analysis of a 30-day Morbidity Assessment Using the European Association of Urology Quality Criteria for Standardized Reporting. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.06.005. Klemm J; Koelker M; Shariat SF; Fisch M; Vetterlein MW Eur Urol Focus; 2024 Jul; 10(4):674-675. PubMed ID: 37806850 [No Abstract] [Full Text] [Related]
8. Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia's Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596. Contieri R; Hensley PJ; Kamat AM Eur Urol Oncol; 2024 Apr; 7(2):301. PubMed ID: 37806840 [No Abstract] [Full Text] [Related]
9. Reply to Valeria Panebianco, Francesco Del Giudice, Yoshifumi Narumi, Giuseppe Simone, Ettore De Berardinis, and James Catto's Letter to the Editor re: Helena Vila-Reyes, G. Joel De Castro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol 2021;79:e35-e36. Vila-Reyes H; Joel DeCastro G; McKiernan JM Eur Urol; 2021 Feb; 79(2):e54-e55. PubMed ID: 33248798 [No Abstract] [Full Text] [Related]
10. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Vetterlein MW; Klemm J; Gild P; Bradtke M; Soave A; Dahlem R; Fisch M; Rink M Eur Urol; 2020 Jan; 77(1):55-65. PubMed ID: 31473012 [TBL] [Abstract][Full Text] [Related]
11. Re: Helena Vila-Reyes, G. Joel DeCastro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol 2021;79:e35-e36. Panebianco V; Del Giudice F; Narumi Y; Simone G; De Berardinis E; Catto JWF Eur Urol; 2021 Feb; 79(2):e52-e53. PubMed ID: 33261940 [No Abstract] [Full Text] [Related]
12. Reply to Marco Moschini, Francesco Montorsi, Giuseppe Rosiello, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Stamatios Katsimperis, Lazaros Tzelves, Zafer Tandogdu, et al. Complications After Radical Cystectomy: A Systematic Review and Meta-analysis of Randomized Controlled Trials with a Meta-regression Analysis. Eur Urol Focus 2023;9:920-9. Katsimperis S; Tzelves L; Tandogdu Z; Ta A; Geraghty R; Bellos T; Manolitsis I; Pyrgidis N; Schulz GB; Sridhar A; Shaw G; Kelly J; Skolarikos A Eur Urol Focus; 2024 Sep; 10(5):859. PubMed ID: 38749880 [No Abstract] [Full Text] [Related]
13. Re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020;77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Vila-Reyes H; DeCastro GJ; McKiernan JM Eur Urol; 2021 Jan; 79(1):e35-e36. PubMed ID: 32829975 [No Abstract] [Full Text] [Related]
14. Reply to Chao Quan, Jinbo Chen, and Jiao Hu's Letter to the Editor re: Giuseppe Basile, Marco Bandini, Ewan A. Gibb, et al. Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer: 3-Year Median Follow-up Update of PURE-01 Trial. Clin Cancer Res 2022;28:5107-14. Basile G; Bandini M; Montorsi F; Necchi A Eur Urol; 2023 Apr; 83(4):e111-e112. PubMed ID: 36707359 [No Abstract] [Full Text] [Related]
15. Re: Jakob Klemm, Michael Rink, Markus von Deimling, et al. Time-to-complication Patterns After Radical Cystectomy: A Secondary Analysis of a 30-day Morbidity Assessment Using the European Association of Urology Quality Criteria for Standardized Reporting. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.06.005. Montorsi F; Moschini M; Gandaglia G; Briganti A Eur Urol Focus; 2024 Jul; 10(4):670. PubMed ID: 37748951 [No Abstract] [Full Text] [Related]
16. Re: Jakob Klemm, Michael Rink, Markus von Deimling, et al. Time-to-complication Patterns After Radical Cystectomy: A Secondary Analysis of a 30-day Morbidity Assessment Using the European Association of Urology Quality Criteria for Standardized Reporting. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.06.005. Furrer MA; Wuethrich PY Eur Urol Focus; 2024 Jul; 10(4):676-677. PubMed ID: 37806852 [No Abstract] [Full Text] [Related]
17. Reply to Marco Moschini, Francesco Montorsi, Andrea Salonia, Giorgio Gandaglia and Alberto Briganti's Letter to the Editor Re: Francesco Soria, Matteo Rosazza, Simone Livoti, et al. Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guérin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non-muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized Controlled Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.10.019. Soria F; Gontero P Eur Urol Focus; 2024 Mar; 10(2):247. PubMed ID: 38278711 [No Abstract] [Full Text] [Related]
18. Reply to Yunjin Bai, Yubo Yang, Yin Tang's Letter to the Editor, re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01, Study. Eur Urol 2020;77:636-43. Bandini M; Necchi A Eur Urol; 2020 Jun; 77(6):e159-e160. PubMed ID: 32184002 [No Abstract] [Full Text] [Related]
19. Reply to Paolo Capogrosso, Francesco Montorsi, and Andrea Salonia's Letter to the Editor re: Philipp Mandel, Felix Preisser, Markus Graefen, et al. High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy. Eur Urol 2017;71:848-50. Late Recovery of Erectile Function After Radical Prostatectomy: Should We Modify the Way of Assessment? Mandel P; Graefen M; Huland H; Tilki D Eur Urol; 2017 Dec; 72(6):e179. PubMed ID: 28712858 [No Abstract] [Full Text] [Related]
20. Re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596. Montorsi F; Rosiello G; Gandaglia G Eur Urol Oncol; 2024 Apr; 7(2):300. PubMed ID: 37838554 [No Abstract] [Full Text] [Related] [Next] [New Search]